Skip to main content
. 2019 Jul 20;11(7):1023. doi: 10.3390/cancers11071023

Table 3.

Univariate analysis of PFS and OS in relation to ANGPT2 and NOS3 polymorphisms.

Gene Polymorphisms Genetic Model PFS OS
Median PFS [95% CI] HR [95% CI] p Median OS [95% CI] HR [95% CI] p
ANGPT2
rs3739392 DOM
TT 5.62 [5.03–6.73] 1 14.39 [11.24–16.43] 1
CC/TC 6.14 [3.91–8.54] 0.94 [0.64–1.39] 0.765 13.57 [8.15–18.00] 0.92 [0.60–1.39] 0.679
rs3739391 DOM
CC 5.75 [5.06–6.90] 1 15.11 [12.65–18.50] 1
TT/CT 6.04 [3.91–6.80] 1.13 [0.79–1.63] 0.506 11.14 [8.54–15.64] 1.17 [0.79–1.73] 0.445
rs3739390 DOM
GG 5.75 [5.03–6.60] 1 14.36 [11.24–15.74] 1
CC/GC 6.27 [2.60–12.61] 0.83 [0.52–1.31] 0.416 12.81 [8.15–20.89] 0.88 [0.54–1.44] 0.621
rs55633437 DOM
GG 6.27 [5.75–7.23] 1 15.51 [13.57–18.40] 1
TT/GT 1.58 [0.76–3.32] 4.79 [2.73–8.35] <0.001 4.66 [2.69–8.57] 4.86 [2.73–8.67] <0.001
rs3020221 REC
GG/GA 5.78 [5.06–6.60] 1 12.81 [10.35–15.24] 1
AA 8.77 [4.01–10.78] 0.72 [0.45–1.14] 0.163 18.99 [13.57–36.47] 0.53 [0.31–0.92] 0.024
rs1961222 DOM
GG 5.32 [3.19–6.60] 1 11.24 [8.54–15.01] 1
AA /GA 6.04 [5.09–8.02] 0.93 [0.65–1.34] 0.712 16.43 [13.57–18.99] 0.67 [0.46–0.99] 0.044
rs17063434 DOM
TT 5.62 [5.03–6.14] 1 0.84 [11.99–17.77] 1
CC /TC 6.80 [6.14–8.54] 0.93 [0.55–1.56] 0.779 11.24 [8.15–15.64] 1.59 [0.94–2.69] 0.084
rs2916747
TT 5.78 [5.06–6.60] 1 14.39 [11.99–16.43] 1
TC 6.27 [1.97–13.83] 0.61 [0.34–1.10] 0.102 11.70 [4.20–27.79] 1.09 [0.61–1.94] 0.784
NOS3
NOS3 +894 (rs1799983) DOM
GG 5.22 [2.83–6.11] 1 15.74 [9.23–18.50] 1
GT/TT 6.60 [5.32–8.18] 0.81 [0.57–1.16] 0.251 14.29 [11.14–15.51] 1.14 [0.77–1.68] 0.527
VNTR4a4b DOM
4bb 5.06 [3.75–6.11] 1 11.99 [9.10–14.85] 1
4aa/4ab 7.65 [6.08–12.61] 0.54 [0.36–0.80] 0.002 17.15 [14.59–20.89] 0.68 [0.44–1.05] 0.080
NOS3-786 (rs2070744) DOM
TT 3.25 [2.33–5.06] 1 9.10 [6.80–14.29] 1
CC/TC 7.03 [6.08–8.67] 0.43 [0.30–0.63] <0.001 15.60 [13.86–19.51] 0.65 [0.44–0.97] 0.036

Abbreviations: DOM, dominant; REC; recessive; VNTR, variable number of tandem repeats; PFS, progression-free survival; OS, overall survival; HR, hazard ratio.